跳至主要内容
临床试验/CTRI/2024/08/071992
CTRI/2024/08/071992尚未招募不适用

Polymyxin B combined with sulbactam versus Polymyxin B combined with tigecycline in the treatment of carbapenem resistant acinetobacter baumanni pneumoniae

未提供1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2024年8月22日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
48
试验地点
1
主要终点
ICU MORTALITY

研究概览

简要总结

There is no clear “standard of care” antibiotic regimen for CRAB infections.  The current preferred approach for treating CRAB pneumonia in our intensive care unit is a combination of polymixin B with tigecycline or salbactam, depending on the physician choice. There is no data comparing the effectiveness of combination of Poymyxin B with sulbactam and Polymyxin B with Tigecyclline for CRAB pneumonia. Hence the need to conduct the study.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis of HAP or VAP.

排除标准

  • Isolation of more than one organism in respiratory specimens CRAB resistant to tigecycline and colistin Pregnant patients Patients not willing to participate in the study.

结局指标

主要结局

ICU MORTALITY

时间窗: At baseline, week 7, week 10 and week 14.

次要结局

  • Length of hospital stay(Length of ICU stay)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Anthur Ajay Nair

PSG Hospitals

研究点 (1)

Loading locations...

相似试验